References:
- Bodkin CL, et al. 2005. OnabotulinumtoxinA therapy during pregnancy. Mov Disord 20(8): 1081-1082.
- Briggs J, et al. 2005. Drugs in pregnancy and lactation, 7th 174-175. Lippincott Williams & Wilkins: Philadelphia.
- Brin MF, et al. 2016. Pregnancy outcomes following exposure to onabotulinumtoxinA. Pharmacoepidemiology and Drug Safety. 25: 179–187.
- De Oliveira Monteiro E. 2006. Botulinum toxin and pregnancy. Skinmed 5(6): 308.
- Li Yim and Weir CR. 2010. Botulinum toxin and pregnancy – cautionary tale. Strabismus 18(2): 65-66.
- Morgan J.C., et al. 2006. Botulinum toxin A during pregnancy: a survey of treating physicians. J Neurol Neurosurg Psychiatry 77 (1) 117-119.
- Newman W.J., et al 2004. OnabotulinumtoxinA therapy during pregnancy. Mov Disord 19(11): 1384-1385.
- Polo JM, et al. 1996. Botulism and pregnancy. Lancet 348: 195.
- Robinson AY, Grogan PM. OnabotulinumtoxinA successfully used as migraine prophylaxis during pregnancy: a case report. Mil Med. 2014 Jun;179(6):e703-4.
- Clair EH, et al. 1975. Observations of an infant born to a mother with botulism. J Pediatr 87: 658.
- Wataganara T, et al. 2009. Treatment of severe achalasia during pregnancy with esophagoscopic injection of botulinum toxin A: a case report. J Perinatol 29(9): 639.
